Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.
Pose E, Napoleone L, Amin A, Campion D, Jimenez C, Piano S, Roux O, Uschner FE, de Wit K, Zaccherini G, Alessandria C, Angeli P, Bernardi M, Beuers U, Caraceni P, Durand F, Mookerjee RP, Trebicka J, Vargas V, Andrade RJ, Carol M, Pich J, Ferrero J, Domenech G, Llopis M, Torres F, Kamath PS, Abraldes JG, Solà E, Ginès P. Pose E, et al. Among authors: bernardi m. Lancet Gastroenterol Hepatol. 2020 Jan;5(1):31-41. doi: 10.1016/S2468-1253(19)30320-6. Epub 2019 Oct 10. Lancet Gastroenterol Hepatol. 2020. PMID: 31607677 Free article. Clinical Trial.
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.
Bolondi L, Piscaglia F, Gatta A, Salerno F, Bernardi M, Ascione A, Ferraù O, Sacerdoti D, Visentin S, Trevisani F, Mazzanti R, Donati G, Arena U, Gentilini P; DOC (Decrease Of Complications in cirrhosis) Study Group. Bolondi L, et al. Among authors: bernardi m. Clin Gastroenterol Hepatol. 2006 Nov;4(11):1395-402. doi: 10.1016/j.cgh.2006.06.005. Epub 2006 Aug 22. Clin Gastroenterol Hepatol. 2006. PMID: 16931172 Clinical Trial.
Daily profile of circulating C-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects: relationship with renal function.
Zambruni A, Trevisani F, Gülberg V, Caraceni P, Domenicali M, Cantarini MC, Cappa FM, Di Micoli A, Magini G, Labate-Morselli AM, Gerbes AL, Bernardi M. Zambruni A, et al. Among authors: bernardi m. Scand J Gastroenterol. 2007 May;42(5):642-7. doi: 10.1080/00365520601013739. Scand J Gastroenterol. 2007. PMID: 17454886
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.
Zambruni A, Trevisani F, Di Micoli A, Savelli F, Berzigotti A, Bracci E, Caraceni P, Domenicali M, Felline P, Zoli M, Bernardi M. Zambruni A, et al. Among authors: bernardi m. J Hepatol. 2008 Mar;48(3):415-21. doi: 10.1016/j.jhep.2007.11.012. Epub 2007 Dec 26. J Hepatol. 2008. PMID: 18194821 Clinical Trial.
1,392 results